<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> and abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> are the risk factors for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The greater amount of adipose tissue the higher level of leptin, adipocytocin with potential proatherogenic properties </plain></SENT>
<SENT sid="2" pm="."><plain>THE AIM OF THE STUDY: was to evaluate the leptin level in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and leptin's role in the pathogenesis of cerebrovascular diseases </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIAL AND METHODS: We examined 45 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and 17 cases without <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> diseases, matched with age and gender </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> subjects we examined <z:chebi fb="23" ids="18059">lipid</z:chebi> pattern (cholesterol, <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>, <z:chebi fb="1" ids="47774">LDL-cholesterol</z:chebi>, triglicerydes), blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level, blood pressure, BMI (body mass index) and central fat--measured by WC (waist circumference) and W/HR (waist to hip ratio) </plain></SENT>
<SENT sid="5" pm="."><plain>On the basis of these parameters we diagnosed the presence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, according to American Heart Association 2005 </plain></SENT>
<SENT sid="6" pm="."><plain>Leptin level was measured by an enzyme linked immunosorbent assay </plain></SENT>
<SENT sid="7" pm="."><plain>Ultrasonographic scanning of the carotid artery was performed in every patient to evaluate the CIMT and <z:hpo ids='HP_0002634'>arteriosclerosis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Hyperleptiemia is more often present in patient with abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo> (p &lt; 0.001) and in subjects with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (p &lt; 0.01)--the constellation of risk factors predisposing to <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>There is no independent association between increased leptin concentrations and <z:chebi fb="105" ids="17234">glucose</z:chebi> levels and presence of <z:hpo ids='HP_0000822'>hypertension</z:hpo> (p &gt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>Hyperleptynemia is associated with CIMT--an early marker of asymptomatic <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Leptin can be the <z:hpo ids='HP_0001297'>stroke</z:hpo> manifestation of <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>There is necessary to further evaluation of leptin's role in the pathogenesis of cerebrovascular diseases and its potential role in prophylaxis of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>